10-Q Filing

CVS HEALTH CORP CIK: 64803 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001558370-18-006683`
Period End Date	20180630
Filing Date	20180808
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	cvs-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 90 Cash Flow Statement 83 Comprehensive Income 24

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred Stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$43.81B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.70B	USD	Point-in-time
Preferred Stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred Stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred Stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$96.00M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$111.00M	USD	Point-in-time
Preferred Stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$14.16B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$13.18B	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$14.92B	USD	Point-in-time
Inventories	`InventoryNet`	$15.30B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$945.00M	USD	Point-in-time
Common Stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$799.00M	USD	Point-in-time
Common Stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common Stock, shares issued (in shares)	`CommonStockSharesIssued`	1.72B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$73.79B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$31.23B	USD	Point-in-time
Common Stock, shares issued (in shares)	`CommonStockSharesIssued`	1.71B	shares	Point-in-time
Common Stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.01B	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.29B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.25B	USD	Point-in-time
Common Stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.02B	shares	Point-in-time
Goodwill	`Goodwill`	$34.22B	USD	Point-in-time
Treasury Stock, shares (in shares)	`TreasuryStockShares`	697.00M	shares	Point-in-time
Treasury Stock, shares (in shares)	`TreasuryStockShares`	698.00M	shares	Point-in-time
Goodwill	`Goodwill`	$38.45B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$13.32B	USD	Point-in-time
Shares held in trust: 1 share at September 30, 2017 and December 31, 2016 (in shares)	`CommonStockSharesHeldInEmployeeTrustShares`	1.00M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$13.63B	USD	Point-in-time
Shares held in trust: 1 share at September 30, 2017 and December 31, 2016 (in shares)	`CommonStockSharesHeldInEmployeeTrustShares`	1.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.71B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.53B	USD	Point-in-time
Total assets	`Assets`	$133.29B	USD	Point-in-time
Total assets	`Assets`	$95.13B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.86B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.57B	USD	Point-in-time
Claims and discounts payable	`ClaimsAndDiscountsPayable`	$10.36B	USD	Point-in-time
Claims and discounts payable	`ClaimsAndDiscountsPayable`	$11.74B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.64B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.61B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$1.28B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.54B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.54B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$31.49B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$30.65B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$61.57B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$22.18B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$3.00B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$3.05B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.61B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.56B	USD	Point-in-time
Total Liabilities	`Liabilities`	$57.44B	USD	Point-in-time
Total Liabilities	`Liabilities`	$97.68B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,716 shares issued and 1,017 shares outstanding at June 30, 2018 and 1,712 shares issued and 1,014 shares outstanding at December 31, 2017	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,716 shares issued and 1,017 shares outstanding at June 30, 2018 and 1,712 shares issued and 1,014 shares outstanding at December 31, 2017	`CommonStockValue`	$17.00M	USD	Point-in-time
Capital surplus	`AdditionalPaidInCapital`	$32.08B	USD	Point-in-time
Capital surplus	`AdditionalPaidInCapital`	$32.26B	USD	Point-in-time
Treasury stock, at cost: 698 shares at June 30, 2018 and 697 shares at December 31, 2017	`TreasuryStockValue`	$37.77B	USD	Point-in-time
Treasury stock, at cost: 698 shares at June 30, 2018 and 697 shares at December 31, 2017	`TreasuryStockValue`	$37.75B	USD	Point-in-time
Shares held in trust: 1 share at June 30, 2018 and December 31, 2017	`CommonStockSharesHeldInEmployeeTrust`	$31.00M	USD	Point-in-time
Shares held in trust: 1 share at June 30, 2018 and December 31, 2017	`CommonStockSharesHeldInEmployeeTrust`	$31.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$43.56B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$40.97B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-165.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$141.00M	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$35.61B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$37.69B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$4.00M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$4.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$35.61B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$133.29B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$95.13B	USD	Point-in-time

Income Statement 90 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$45.69B	USD	1 Quarter
Net revenues	`Revenues`	$46.71B	USD	1 Quarter
Net revenues	`Revenues`	$92.40B	USD	2 Qtrs
Net revenues	`Revenues`	$90.20B	USD	2 Qtrs
Cost of revenue	`CostOfGoodsAndServicesSold`	$76.70B	USD	2 Qtrs
Cost of revenue	`CostOfGoodsAndServicesSold`	$38.76B	USD	1 Quarter
Cost of revenue	`CostOfGoodsAndServicesSold`	$39.51B	USD	1 Quarter
Cost of revenue	`CostOfGoodsAndServicesSold`	$78.34B	USD	2 Qtrs
Gross profit	`GrossProfit`	$6.93B	USD	1 Quarter
Gross profit	`GrossProfit`	$13.50B	USD	2 Qtrs
Gross profit	`GrossProfit`	$14.06B	USD	2 Qtrs
Gross profit	`GrossProfit`	$7.20B	USD	1 Quarter
Goodwill impairments	`GoodwillImpairmentLoss`	$135.00M	USD	2 Qtrs
Goodwill impairments	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Goodwill impairments	`GoodwillImpairmentLoss`	$3.92B	USD	2 Qtrs
Goodwill impairments	`GoodwillImpairmentLoss`	$135.00M	USD	1 Quarter
Goodwill impairments	`GoodwillImpairmentLoss`	$3.92B	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$4.67B	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$4.87B	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$9.45B	USD	2 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$9.78B	USD	2 Qtrs
Operating expenses	`OperatingExpenses`	$9.59B	USD	2 Qtrs
Operating expenses	`OperatingExpenses`	$4.81B	USD	1 Quarter
Operating profit (loss)	`OperatingIncomeLoss`	$2.12B	USD	1 Quarter
Operating profit (loss)	`OperatingIncomeLoss`	$359.00M	USD	2 Qtrs
Operating profit (loss)	`OperatingIncomeLoss`	$-1.59B	USD	1 Quarter
Operating profit (loss)	`OperatingIncomeLoss`	$3.91B	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-247.00M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-499.00M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-475.00M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-948.00M	USD	2 Qtrs
Other expense	`OtherNonoperatingExpense`	$3.00M	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$7.00M	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$14.00M	USD	2 Qtrs
Other expense	`OtherNonoperatingExpense`	$6.00M	USD	2 Qtrs
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$3.40B	USD	2 Qtrs
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.86B	USD	1 Quarter
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-595.00M	USD	2 Qtrs
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.06B	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$766.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$969.00M	USD	2 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$497.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$1.34B	USD	2 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-1.56B	USD	2 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$2.06B	USD	2 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-2.56B	USD	1 Quarter
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.00M	USD	1 Quarter
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-8.00M	USD	2 Qtrs
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.00M	USD	2 Qtrs
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$1.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-1.56B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-2.56B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.05B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$1.10B	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$2.05B	USD	2 Qtrs
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$1.10B	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$-2.56B	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$-1.56B	USD	2 Qtrs
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$2.00	USD	2 Qtrs
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-2.52	USD	1 Quarter
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.54	USD	2 Qtrs
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.07	USD	1 Quarter
Loss from discontinued operations attributable to CVS Health (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.01	USD	2 Qtrs
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$-1.54	USD	2 Qtrs
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$-2.52	USD	1 Quarter
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$1.99	USD	2 Qtrs
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareBasic`	$1.07	USD	1 Quarter
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	1 Quarter
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	2 Qtrs
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	1 Quarter
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	2 Qtrs
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.07	USD	1 Quarter
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-2.52	USD	1 Quarter
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.54	USD	2 Qtrs
Income (loss) from continuing operations attributable to CVS Health (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.99	USD	2 Qtrs
Loss from discontinued operations attributable to CVS Health (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.01	USD	2 Qtrs
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$-1.54	USD	2 Qtrs
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$1.07	USD	1 Quarter
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$1.98	USD	2 Qtrs
Net income (loss) attributable to CVS Health (in dollars per share)	`EarningsPerShareDiluted`	$-2.52	USD	1 Quarter
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.02B	shares	1 Quarter
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.02B	shares	2 Qtrs
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.02B	shares	1 Quarter
Weighted average shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.03B	shares	2 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.00	USD	2 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.00	USD	2 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter

Cash Flow Statement 83 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$88.34B	USD	2 Qtrs
Cash receipts from customers	`ProceedsFromCustomers`	$87.98B	USD	2 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsToSuppliers`	$72.50B	USD	2 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsToSuppliers`	$73.75B	USD	2 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$8.47B	USD	2 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$7.00B	USD	2 Qtrs
Interest received	`ProceedsFromInterestReceived`	$194.00M	USD	2 Qtrs
Interest received	`ProceedsFromInterestReceived`	$10.00M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$560.00M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$539.00M	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.35B	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.53B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.53B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.29B	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$888.00M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$912.00M	USD	2 Qtrs
Proceeds from sale of property and equipment and other assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$13.00M	USD	2 Qtrs
Proceeds from sale of property and equipment and other assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$7.00M	USD	2 Qtrs
Acquisitions (net of cash acquired) and other investments	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$275.00M	USD	2 Qtrs
Acquisitions (net of cash acquired) and other investments	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$573.00M	USD	2 Qtrs
Purchase of available-for-sale investments	`PaymentsToAcquireShortTermInvestments`	$36.00M	USD	2 Qtrs
Maturity of available-for-sale investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$16.00M	USD	2 Qtrs
Maturity of available-for-sale investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$37.00M	USD	2 Qtrs
Proceeds from sale of subsidiary	`ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates`	$725.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.13B	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-752.00M	USD	2 Qtrs
Decrease in short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-1.28B	USD	2 Qtrs
Decrease in short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-774.00M	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromDebtNetOfIssuanceCosts`	$39.38B	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.00M	USD	2 Qtrs
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$-446.00M	USD	2 Qtrs
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$-446.00M	USD	Point-in-time
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$3.96B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.03B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.02B	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$189.00M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$130.00M	USD	2 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$37.00M	USD	2 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$60.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$37.62B	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-5.63B	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.24B	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$42.16B	USD	2 Qtrs
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.52B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.28B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.90B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.06B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.52B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.28B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.90B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.06B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-1.56B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-2.56B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.05B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$1.10B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.24B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.29B	USD	2 Qtrs
Goodwill impairments	`GoodwillImpairmentLoss`	$135.00M	USD	2 Qtrs
Goodwill impairments	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Goodwill impairments	`GoodwillImpairmentLoss`	$3.92B	USD	2 Qtrs
Goodwill impairments	`GoodwillImpairmentLoss`	$135.00M	USD	1 Quarter
Goodwill impairments	`GoodwillImpairmentLoss`	$3.92B	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$108.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$110.00M	USD	2 Qtrs
Deferred income taxes and other noncash items	`DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems`	$21.00M	USD	2 Qtrs
Deferred income taxes and other noncash items	`DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems`	$252.00M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$114.00M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.06B	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-492.00M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-369.00M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$31.00M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$45.00M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$129.00M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$38.00M	USD	2 Qtrs
Accounts payable and claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$180.00M	USD	2 Qtrs
Accounts payable and claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$1.04B	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.34B	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.14B	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$141.00M	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-44.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.53B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.29B	USD	2 Qtrs

Comprehensive Income 24 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-1.56B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-2.56B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.05B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$1.10B	USD	1 Quarter
Foreign currency translation adjustments, net of tax	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-27.00M	USD	1 Quarter
Foreign currency translation adjustments, net of tax	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-10.00M	USD	1 Quarter
Foreign currency translation adjustments, net of tax	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-26.00M	USD	2 Qtrs
Foreign currency translation adjustments, net of tax	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00M	USD	2 Qtrs
Net cash flow hedges, net of tax	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-4.00M	USD	1 Quarter
Net cash flow hedges, net of tax	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$339.00M	USD	2 Qtrs
Net cash flow hedges, net of tax	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$1.00M	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-10.00M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$313.00M	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-31.00M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.00M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-1.25B	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.05B	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-2.59B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.09B	USD	1 Quarter
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$2.05B	USD	2 Qtrs
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$-1.25B	USD	2 Qtrs
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$-2.59B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.